Dr. Scott Friedman

1. Dr. Scott L Friedman. Liver disease, NAFLD, NASH Expert. Biography. 0

Dr. Scott Friedman, MD, explains the critical research into liver fibrosis and fatty liver disease. He details his pioneering work on the mechanisms of liver...

2. What is Non-Alcoholic Fatty Liver Disease? NAFLD Diagnostic Criteria. 1

Dr. Scott Friedman, MD, explains non-alcoholic fatty liver disease (NAFLD) and its diagnostic criteria. He details the progression from simple fat accumulation to the more...

3. Non-obese patients with NAFLD [fatty liver disease]. ‘Lean NASH’. 2

Dr. Scott Friedman, MD, explains how non-alcoholic fatty liver disease (NAFLD) can occur in lean patients. He details the concept of 'Lean NASH' and its...

4. Diagnostic tests for fatty liver disease, NAFLD. FibroScan and MR Elastography. 3

Dr. Scott Friedman, MD, explains how to diagnose NAFLD and NASH. He details why standard liver enzyme tests are insufficient.

5. Can fatty liver disease be reversed? NAFLD and NASH treatment. 4

Dr. Scott Friedman, MD, explains how NAFLD and NASH can be reversed. He confirms that liver fat can be cleared relatively quickly.

6. How NASH differs from NAFLD. What drives progression to NASH? 5

Dr. Scott Friedman, MD, explains how non-alcoholic steatohepatitis (NASH) differs from non-alcoholic fatty liver disease (NAFLD). He details the key drivers of progression from simple...

7. Genetic tests to find risks for liver disease [NAFLD and NASH]. 6

Dr. Scott Friedman, MD, explains how genetic tests can identify risks for NASH. He clarifies that genetic screening is not a primary diagnostic tool for...

8. Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7

Dr. Scott Friedman, MD, explains the critical link between the gut microbiome and non-alcoholic fatty liver disease. He details how diet, antibiotics, and household environments...

9. Food supplements and generic drugs for NASH and NAFLD. 8

Dr. Scott Friedman, MD, explains how the gut microbiome influences NASH and NAFLD. He discusses innovative treatment strategies like 'bugs as drugs' and fecal microbiota...

10. Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9

Dr. Scott Friedman, MD, explains the central role of hepatic stellate cells in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

11. Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10

Dr. Scott Friedman, MD, explains the link between fatty liver disease and liver cancer. He details why some patients with NASH develop cancer before cirrhosis...

12. When new drugs will be approved for fatty liver disease? 11

Dr. Scott Friedman, MD, explains why no medications are yet approved for non-alcoholic steatohepatitis (NASH). He details the disease's complexity and the need for combination...

13. Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12

Dr. Scott Friedman, MD, explains the most advanced drug candidates for NASH therapy. He details the mechanisms of action for Obeticholic acid, Resmetirom, and Semaglutide....

14. Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13

Dr. Scott Friedman, MD, explains how coffee consumption reduces the risk of liver disease. He discusses compelling epidemiological data showing a protective effect from regular...

15. Future of liver disease treatment. Xenotransplantation of liver. 14

Dr. Scott Friedman, MD, explains the future of hepatology treatment. He details the remarkable progress from the 1980s to today's curative hepatitis C therapies and...

16. FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15

Dr. Scott Friedman, MD, explains the critical questions patients with fatty liver disease should ask their doctors. He discusses the impact of NAFLD and NASH...

17. How to improve health of your liver? Difficulty to keep low weight. 16

Dr. Scott Friedman, MD, explains how to improve liver health. He details the critical role of weight loss and exercise for patients with NASH.

18. Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17

Dr. Scott Friedman, MD, explains how most patients with fatty liver disease and NASH are asymptomatic. He clarifies that alcohol is often not the cause....

19. ‘Mentorship is crucial for successful medical career’. Prof. Scott L. Friedman. 18

Dr. Scott Friedman, MD, explains the profound importance of mentoring for a successful medical career. He details how effective guidance impacts trainees at all levels....

Medical Practice